Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Measurements to Assess Severity of Epicardial Stenoses

NCT: NCT00760630 · TERMINATED

NCT IDNCT00760630
StatusTERMINATED
Start Date2009-12
Completion2012-02-24
SponsorUniversity of Cincinnati (OTHER)
First posted
Last updated

Brief Summary

Newly developed diagnostic parameters have potential to differentiate between epicardial disease and microvascular dysfunction with the help of anatomical details and physiological endpoints and can be used in present clinical settings.

Frequently Asked Questions

What is Measurements to Assess Severity of Epicardial Stenoses?

Measurements to Assess Severity of Epicardial Stenoses is a clinical trial registered under NCT00760630. Current status: TERMINATED.

What is the status of NCT00760630?

The current status of NCT00760630 (Measurements to Assess Severity of Epicardial Stenoses) is: TERMINATED.

When did Measurements to Assess Severity of Epicardial Stenoses start?

Measurements to Assess Severity of Epicardial Stenoses started on 2009-12.

Related Devices

K243881HeartSee™ Cardiac P.E.T. Processing Software For Myocardial Perfusion and Coronary Flow Reserve (CFR) Version 4Bracco Diagnostics, Inc.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑